AXS Cannabis ETF

THCX - Global stocks

THCX seeks to track the performance of the Innovation Labs Cannabis Index, which contains companies expected to benefit from the burgeoning hemp and legal marijuana industries. The fund is appropriate for investors seeking long-term growth. THCX is subject to equity market risk, foreign security risk and risk that cannabis stocks may underperform the broad market.

THCX isn’t eligible for Tax-Loss Harvesting, since we can’t find a viable alternate fund.

Price
$17.68
as of 04:00 PM EDT, 10/02/2023
Risk rating
Very high
We base risk ratings on the volatility, or the size and frequency of price fluctuations, of the investment. Typically, a more volatile investment has a higher risk rating.
Expense ratio
0.75%
The percentage of fund assets used to cover operating expenses and management fees.
52-week high
$36.00
The highest share price in the past year.
52-week low
$16.29
The lowest share price in the past year.
Dividend yield
1.44%
The average percentage of dividends paid relative to the share price over the past year.
Net assets
$15.29M
The total value of all assets held by the fund.
Volume
4,213
The average trading volume over the past 90 days.

View prospectus

Investing is easy

when it’s automated

Get started

Start with one of Wealthfront’s expert-built portfolios and then customize your portfolio with hundreds of investment possibilities.

Get started